The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(6-Methoxy-1H-indol-2-yl)(4-(2-(4-methoxyphenoxy)ethyl)piperazin-1-yl)methanone ID: ALA4540693
PubChem CID: 38417721
Max Phase: Preclinical
Molecular Formula: C23H27N3O4
Molecular Weight: 409.49
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(OCCN2CCN(C(=O)c3cc4ccc(OC)cc4[nH]3)CC2)cc1
Standard InChI: InChI=1S/C23H27N3O4/c1-28-18-5-7-19(8-6-18)30-14-13-25-9-11-26(12-10-25)23(27)22-15-17-3-4-20(29-2)16-21(17)24-22/h3-8,15-16,24H,9-14H2,1-2H3
Standard InChI Key: AOEZTGSRIVCHEA-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 33 0 0 0 0 0 0 0 0999 V2000
14.0635 -13.5040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0611 -12.6827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7717 -12.2678 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.3480 -12.2721 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.4867 -12.6823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1952 -12.2709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1970 -11.4493 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.4841 -11.0406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7694 -11.4495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9050 -11.0412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6165 -11.4504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3287 -11.0424 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.0402 -11.4515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0355 -12.2713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7462 -12.6845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4593 -12.2723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4573 -11.4468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7461 -11.0414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1714 -12.6847 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.1718 -13.5060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4014 -13.9847 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.7318 -13.9807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4776 -14.7628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6602 -14.7634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2558 -15.4711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6637 -16.1786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4843 -16.1741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8890 -15.4658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2569 -16.8874 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.4397 -16.8894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
2 4 2 0
3 5 1 0
3 9 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
7 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
16 19 1 0
19 20 1 0
1 21 1 0
21 24 1 0
23 22 1 0
22 1 2 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
26 29 1 0
29 30 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 409.49Molecular Weight (Monoisotopic): 409.2002AlogP: 3.02#Rotatable Bonds: 7Polar Surface Area: 67.03Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.53CX LogP: 2.47CX LogD: 2.41Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.65Np Likeness Score: -1.17
References 1. Moritz AE, Free RB, Weiner WS, Akano EO, Gandhi D, Abramyan A, Keck TM, Ferrer M, Hu X, Southall N, Steiner J, Aubé J, Shi L, Frankowski KJ, Sibley DR.. (2020) Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D3 Dopamine Receptor Agonist., 63 (10): [PMID:32342685 ] [10.1021/acs.jmedchem.0c00424 ]